Inhibitor for blood phosphorus level elevation

Abstract

The present invention provides an inhibitor for blood phosphorus level elevation comprising a lactic acid bacterium as an active ingredient. The inhibitor for blood phosphorus level elevation of the present invention is highly safe, is readily administerable, and can sufficiently inhibit a blood phosphorus level elevation.

1 . An inhibitor for blood phosphorus level elevation comprising a lactic acid bacterium as an active ingredient,
 wherein the lactic acid bacterium is at least one selected from the group consisting of  Bifidobacterium bifidum, B. longum, B. infantis, B. animalis, B. pseudolongum, B. dentium, Lactobacillus acidophilus, L. animalis, L. brevis, L. bulgaricus, L. casei, L. delbrueckii, L. plantarum, Lactococcus lactis  subsp.  lactis, Enterococcus faecium , and  Enterococcus faecalis.      
     
     
         2 - 3 . (canceled) 
     
     
         4 . The inhibitor for blood phosphorus level elevation according to  claim 1 , wherein the inhibitor for blood phosphorus level elevation is in an oral dosage form. 
     
     
         5 . The inhibitor for blood phosphorus level elevation according to  claim 4 , wherein the inhibitor for blood phosphorus level elevation is in at least one form selected from the group consisting of soft capsules, hard capsules, and seamless capsules. 
     
     
         6 . The inhibitor for blood phosphorus level elevation according to  claim 4 , wherein the inhibitor for blood phosphorus level elevation has acid resistance. 
     
     
         7 . The inhibitor for blood phosphorus level elevation according to  claim 4 , wherein the inhibitor for blood phosphorus level elevation is enteric. 
     
     
         8 . The inhibitor for blood phosphorus level elevation according to  claim 1 , further comprising an oligosaccharide. 
     
     
         9 . The inhibitor for blood phosphorus level elevation according to  claim 5 , wherein the inhibitor for blood phosphorus level elevation has acid resistance. 
     
     
         10 . The inhibitor for blood phosphorus level elevation according to  claim 5 , wherein the inhibitor for blood phosphorus level elevation is enteric. 
     
     
         11 . The inhibitor for blood phosphorus level elevation according to  claim 4 , further comprising an oligosaccharide. 
     
     
         12 . The inhibitor for blood phosphorus level elevation according to  claim 5 , further comprising an oligosaccharide. 
     
     
         13 . The inhibitor for blood phosphorus level elevation according to  claim 6 , further comprising an oligosaccharide. 
     
     
         14 . The inhibitor for blood phosphorus level elevation according to  claim 7 , further comprising an oligosaccharide. 
     
     
         15 . The inhibitor for blood phosphorus level elevation according to  claim 8 , further comprising an oligosaccharide. 
     
     
         16 . The inhibitor for blood phosphorus level elevation according to  claim 4 , further comprising an oligosaccharide.